Structures by: Liu H. Q.
Total: 23
C22H20AgClN2O5S2
C22H20AgClN2O5S2
Journal of the Chemical Society, Dalton Transactions (2000) 13 1985
a=10.618(2)Å b=11.047(2)Å c=11.621(2)Å
α=69.48(3)° β=68.38(3)° γ=72.25(3)°
C24H24AgClN2O6S2
C24H24AgClN2O6S2
Journal of the Chemical Society, Dalton Transactions (2000) 13 1985
a=9.0880(10)Å b=11.0640(10)Å c=14.898(2)Å
α=92.90(1)° β=105.69(2)° γ=113.98(2)°
C46H46Ag4N8O16S4
C46H46Ag4N8O16S4
Journal of the Chemical Society, Dalton Transactions (2000) 13 1985
a=17.211(3)Å b=14.572(3)Å c=21.810(4)Å
α=90.00° β=90.00° γ=90.00°
C24H26N9O10Sm
C24H26N9O10Sm
Journal of the Chemical Society, Dalton Transactions (2000) 19 3253
a=10.3670(10)Å b=26.500(2)Å c=11.4070(10)Å
α=90.00° β=108.77° γ=90.00°
C24H26GdN9O10
C24H26GdN9O10
Journal of the Chemical Society, Dalton Transactions (2000) 19 3253
a=10.3130(10)Å b=26.376(2)Å c=11.3680(10)Å
α=90.00° β=109.000(10)° γ=90.00°
C24H28Cl3N6O2Sm
C24H28Cl3N6O2Sm
Journal of the Chemical Society, Dalton Transactions (2000) 19 3253
a=11.6120(10)Å b=10.9130(10)Å c=21.5700(10)Å
α=90.00° β=100.19° γ=90.00°
C48H48Ag4N8O16S4
C48H48Ag4N8O16S4
Journal of the Chemical Society, Dalton Transactions (2000) 13 1985
a=14.981(4)Å b=16.923(4)Å c=21.999(7)Å
α=90.00° β=90.00° γ=90.00°
C10H8ClCuNO4
C10H8ClCuNO4
Acta Crystallographica Section C (1991) 47, 10 2205-2207
a=8.783(2)Å b=9.304(3)Å c=26.993(5)Å
α=90° β=90° γ=90°
1,3-Bis(5-methyl-3-phenylpyrazol-1-yl)propan-2-ol
C23H24N4O
Acta Crystallographica Section E (2006) 62, 11 o4812-o4813
a=9.8322(19)Å b=12.109(2)Å c=17.141(3)Å
α=90° β=90° γ=90°
1,4,8,11-Tetrakis(carboxymethyl)-5,5,7,12,12,14-hexamethyl- 4,11-diaza-1,8-diazoniacyclotetradecane dichloride dihydrate
C24H46N4O82,2(Cl),2(H2O)
Acta Crystallographica Section E (2008) 64, 5 o885
a=9.977(5)Å b=13.475(7)Å c=11.572(6)Å
α=90.00° β=104.220(9)° γ=90.00°
<i>N</i>-(Imidazol-1-ylmethyl)phthalimide
C12H9N3O2
Acta Crystallographica Section E (2008) 64, 9 o1750
a=7.9905(6)Å b=19.8096(15)Å c=6.9229(5)Å
α=90.00° β=105.5540(10)° γ=90.00°
<i>N</i>-(1<i>H</i>-1,2,3-Benzotriazol-1-ylmethyl)phthalimide
C15H10N4O2
Acta Crystallographica Section E (2008) 64, 9 o1782
a=6.9481(11)Å b=8.0041(13)Å c=12.030(2)Å
α=85.715(3)° β=81.283(3)° γ=73.398(3)°
N-[(3,5-Dimethylpyrazol-1-yl)methyl]phthalimide
C14H13N3O2
Acta Crystallographica Section E (2008) 64, 9 o1733
a=12.285(2)Å b=8.4576(15)Å c=15.6162(19)Å
α=90.00° β=127.566(8)° γ=90.00°
C26H20N2S2
C26H20N2S2
Acta Crystallographica Section C (2000) 56, 8 e348-e349
a=9.230(8)Å b=10.907(6)Å c=12.056(12)Å
α=112.68(6)° β=95.20(7)° γ=106.05(6)°
(4<i>S</i>,5<i>S</i>)-2-(4-Chlorophenyl)-1,3-dioxolane-4,5-dicarboxamide
C11H11ClN2O4
Acta Crystallographica Section E (2009) 65, 8 o1960
a=9.2780(19)Å b=4.7600(10)Å c=13.245(3)Å
α=90.00° β=93.15(3)° γ=90.00°
3-Chloroazepan-2-one
C6H10ClNO
Acta Crystallographica Section E (2010) 66, 2 o438
a=18.776(4)Å b=7.3440(15)Å c=11.109(2)Å
α=90.00° β=103.65(3)° γ=90.00°
(4<i>S</i>,5<i>S</i>)-2-(2-Bromophenyl)-1,3-dioxolane-4,5-dicarboxamide
C11H11BrN2O4
Acta Crystallographica Section E (2009) 65, 4 o841
a=9.4150(19)Å b=14.458(3)Å c=9.6170(19)Å
α=90.00° β=111.14(3)° γ=90.00°
1-Benzoyl-3-chloroazepan-2-one
C13H14ClNO2
Acta Crystallographica Section E (2009) 65, 10 o2383
a=19.564(4)Å b=7.6500(15)Å c=8.4050(17)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2,6-Dichlorophenyl)-5-methyl-1,2-oxazole-4-carboxamide monohydrate
C11H8Cl2N2O2,H2O1
Acta Crystallographica Section E (2011) 67, 12 o3207
a=12.047(2)Å b=8.2290(16)Å c=13.086(3)Å
α=90.00° β=90.00° γ=90.00°
1-Benzyl-6-chloroindoline-2,3-dione
C15H10ClNO2
Acta Crystallographica Section E (2011) 67, 12 o3427
a=7.1870(14)Å b=7.5800(15)Å c=12.012(2)Å
α=80.24(3)° β=84.90(3)° γ=79.74(3)°
6-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
Acta Crystallographica Section E (2012) 68, 1 o14
a=13.077(3)Å b=7.9390(16)Å c=16.673(3)Å
α=90.00° β=101.95(3)° γ=90.00°
Dabigatran etexilate tetrahydrate
C34H41N7O5,4(H2O)
Acta Crystallographica Section E (2012) 68, 12 o3385
a=9.1140(13)Å b=10.9700(14)Å c=18.3830(17)Å
α=88.510(10)° β=85.455(9)° γ=83.034(12)°
1,3-bis(1-phenyl-1H-tetrazol-5-ylthio)propane
C17H16N8S2
Zeitschrift für Kristallographie - New Crystal Structures (2006) 221, 2 185-186
a=16.716(5)Å b=6.4919(19)Å c=18.640(6)Å
α=90.00° β=112.126(5)° γ=90.00°